Research Topics
| Meggan MackaySummaryAffiliation: North Shore University Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Differences in regional brain activation patterns assessed by functional magnetic resonance imaging in patients with systemic lupus erythematosus stratified by disease durationMeggan Mackay
Center for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, New York, United States of America
Mol Med 17:1349-56. 2011..Our hypothesis is further supported by the lack of correlation between regional brain abnormalities on fMRI and the Systemic Lupus International Collaborating Clinics (SLICC) damage index...
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort studyNoa Schwartz
Division of Rheumatology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Arthritis Res Ther 11:R143. 2009..Evidence for the importance of TWEAK in the pathogenesis of lupus nephritis (LN) has been recently introduced. Thus, TWEAK levels may serve as an indication of LN presence and activity...
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosusIlan Ben-Zvi
Division of Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research, Manhasset, New York, United States of America
PLoS ONE 5:e9193. 2010..Our goals were to investigate the relationship between vitamin D levels and disease activity in SLE patients and to investigate the effects of vitamin D on DC activation and expression of IFNalpha-regulated genes in vitro...
Phenotypic characterization of autoreactive B cells--checkpoints of B cell tolerance in patients with systemic lupus erythematosusAnnett M Jacobi
The Center for Autoimmune and Musculoskeletal Diseases, Feinstein Institute for Medical Research, North Shore Long Island Jewish Health System, Manhasset, New York, USA
PLoS ONE 4:e5776. 2009..This methodology enables us to gain insight into the development and fate of DNA-reactive B cells in individual patients with SLE and paves the way ultimately to permit better and more customized therapies...
